sponsor & contact us

A. 高雄醫學大學附設醫院麻醉部
T. 07-3121101 #7033、7035
F. 07-3217874
E. 2020annualmeetingtsa@gmail.com
美商默沙東藥廠股份有限公司-IR401
美商默沙東藥廠股份有限公司-IR401
個人簡介

現職

三軍總醫院麻醉部疼痛治療科主任 
國防醫學院麻醉學科副教授 
台灣急救加護醫學會理事 
台灣急重症醫學雜誌副主編

 

個人經歷

國軍澎湖醫院麻醉科主任 
三軍總醫院附設基隆民診處麻醉疼痛科主任 
三軍總醫院麻醉部主治醫師 
三軍總醫院麻醉部恢復室主任

手術中最適肌張力處置

乙醯膽鹼酯酶抑制劑,例如 neostigmine,傳統上用於逆轉非去極化機神經肌肉阻斷作用。 但這些藥物具有明顯的臨床局限性,例如間接的逆轉機制,有限且不可預測的功效以及不適宜的自主神經反應。Sugammadex是一種選擇性肌肉鬆弛結合劑,專門用於快速逆轉由rocuronium造成的非去極化神經肌肉阻斷。Rocuronium -sugammadex與神經肌肉監測的結合應用可提供許多的臨床效益,包括快速且可預測地逆轉任何程度的肌肉阻斷,提高手術病人的安全性,減少麻醉恢復時的殘餘肌肉阻斷機率,以及更有效地利用醫療資源。

 

The Optimal Muscle Tension assisted procedure service

Acetylcholinesterase inhibitors, such as neostigmine, have traditionally been used for reversal of non-depolarizing neuromuscular blocking agents.However,these drugs have significant limitations,such as indirect mechanisms of reversal, limited and unpredictable efficacy, and undesirable autonomic responses. Sugammadex is a selective relaxant-binding agent specifically developed for rapid reversal of non-depolarizing neuromuscular blockade induced by rocuronium. Rocuronium-sugammadex combined with neuromuscular monitoring provided potential clinical benefits include fast and predictable reversal of any degree of block, increased patient safety, reduced incidence of residual block on recovery, and more efficient use of healthcare resources.